The Manhattan Institute’s Steve Malanga writes that states and actuaries are trying to stifle debate about the growing shortfall in fund assets. Plunging investment returns
People are dying because they can’t pay for prescriptions ‼️
Really? Maybe instead of forcing plans to pay for free contraception, we should have spent that money more wisely. “Literally” who is that literally? The
More on the EpiPen and the FDA
The patent owner of the EpiPen is the target of our wrath over its price. However, as I noted in a previous post, there is
The latest scapegoat of the left-EpiPen
The price of the EpiPen is not the real issue. Frankly I don’t know what the fair price is for an EpiPen or how the
QUINNSCOMMENTARY 